OKYO Pharma Announces $4M Public Offering of Ordinary Shares
Portfolio Pulse from Benzinga Newsdesk
OKYO Pharma has announced a public offering of ordinary shares worth $4 million.
September 13, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
OKYO Pharma's announcement of a $4 million public offering of ordinary shares could potentially dilute existing shareholders' equity.
Public offerings often lead to dilution of existing shareholders' equity, which can negatively impact the stock price in the short term. However, the funds raised can be used for growth and expansion, which could potentially benefit the company in the long term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100